All trials View full record on ClinicalTrials.gov
NCT06523296NARECRUITING
Presence of Anti-RACH Antibodies and Neurocognitive Disorder in Myasthenic or Alzheimers's Patients.
Eligibility check — Phoenix members
Phoenix members see for THIS trial:
- APOE genotype match
- Cognitive status fits inclusion
- Specific exclusions flagged
- Distance to nearest site
Sites
1 location
Start
2024-04-17
Interventions tested
- PROCEDUREAdults with Alzheimer's disease
- PROCEDUREAdults with Myasthenia
- OTHERHealhty controls